INTRODUCTION: Chemical anemia, a common consequence of chemotherapy and environmental toxins, is conventionally attributed to bone marrow suppression. This traditional view may oversimplify the underlying pathology, potentially overlooking critical cellular mechanisms that could serve as novel therapeutic targets. OBJECTIVES: This review aims to (1) propose a paradigm shift in understanding chemical anemia by reframing it as a disorder of mitochondrial dysfunction within erythroid precursors and (2) evaluate the potential of structured exercise as a multi-targeted countermeasure to restore erythropoiesis by addressing this mitochondrial root cause. METHODS: We synthesized evidence from cellular, molecular, and clinical studies to trace the pathway from chemical exposure to erythroid failure. This review integrates data on mitochondrial integrity, oxidative stress, mtDNA damage, heme synthesis, and cell death pathways (ferroptosis/apoptosis). Subsequently, we analyzed the impact of exercise on key molecular regulators (PGC-1α, AMPK) and mitochondrial quality control to assess its therapeutic potential. RESULTS: The synthesis reveals that chemical agents disrupt erythroid maturation primarily by compromising mitochondrial function. This leads to an energetic crisis, stalled heme synthesis, and the activation of ferroptotic and apoptotic pathways, resulting in ineffective erythropoiesis independent of general marrow suppression. Structured exercise is identified as a powerful physiological intervention that activates PGC-1α and AMPK, promoting mitochondrial biogenesis, enhancing mitophagy, and reducing oxidative stress, thereby directly counteracting the proposed pathogenic mechanism. DISCUSSION: By acting as a 'exercise mimetic,' physical activity offers a multi-targeted approach to restore mitochondrial health in erythroid precursors. Nurse-led exercise programs are uniquely positioned to translate this biological rationale into practice. By integrating aerobic and resistance training with patient safety monitoring and technology, nurses can operationalize exercise as a pragmatic, patient-centered, mitochondrial-supportive therapy. CONCLUSION: Reframing chemical anemia as a mitochondrial disorder highlights critical therapeutic vulnerabilities. Structured exercise, delivered through nurse-led programs, represents a promising complementary approach that targets the root cause of ineffective erythropoiesis, offering the potential to improve red blood cell production and reduce reliance on traditional interventions like transfusions and pharmacotherapy.